InMode shares experienced a significant drop of 20% in one trading day, but the decline is seen as excessively harsh. InMode's unique product line bridges the gap between surgical procedures and ...

InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges. High dependence on U.S. revenue from minimally invasive procedures; facing increasing ...

Analysts' price targets for this stock suggest it could soon put up some big gains. Individual investors who want help picking stocks have more than a few options to choose from, including the ...

InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...

InMode is a medical device maker gaining a share of the rapidly growing market for minimally invasive cosmetic procedures. Despite a tough period for making comparisons, InMode reported first-quarter ...

InMode Ltd (NASDAQ:INMD) sock is plunging today after the company reported a Q1 earnings beat, but the annual outlook lagged expectations. InMode reported Q1 sales of $106.07 million, +23.5% Y/Y, ...

We recently compiled a list of 10 Stocks That Will Change the World. In this article, we are going to take a look at where InMode Ltd. (NASDAQ:INMD) stands against the other stocks. If we were to try ...

Shares of medical-device company InMode (NASDAQ: INMD) surged on Thursday after the company reported financial results for the second quarter of 2022. The company keeps beating expectations, and ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...